One of the mechanisms through which MYCN exerts its tumorigenic effect in NB is to activate transcription of genes involved in proliferation, including checkpoint kinase 1 (CHK1), an important regulator of the G1/S and G2/M checkpoints. Here, CHEK1 is linked to neuroblastoma.